EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Targeted Immunoliposomal Delivery of a 5-Fluorouracil Analog in EGFR-Expressing Pancreatic Cancer Models

Esther Frimpong iD, Raviteja Bulusu, Joy Okoro, Xue Zhu, Joshua Ablordeppey, Bo Han, Saunjoo Yoon, Edward Agyare iD

Technology in Cancer Research & Treatment · 2026-07 · 25

DOI: 10.1177/15330338261468414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 30.07.2026. Verfasst von Esther Frimpong und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA. Hauptthemen laut MEDLINE: Fluorouracil, Pancreatic Neoplasms. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIMHD NIH HHS, National Institute of Health (NIH) National Institute on Minority Health and Health Disparities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dysregulated epidermal growth factor receptor (EGFR) signaling is a key mechanism driving cancer progression and metastasis. Owing to its frequent overexpression in pancreatic cancer (PCa), EGFR has become a desirable molecular target for targeted therapies. XYZ-I-73 (N-(5-fluoro-2-oxo-1-(tetrahydrofuran-2-yl)-1,2-dihydropyrimidin-4-yl) dodecanamide), a structural analog of 5-fluorouracil (5-FU), has been previously synthesized and shown to exhibit cytotoxicity against PCa cells.

Methods

XYZ-I-73 was entrapped in liposomes via thin-film hydration and subsequently conjugated to EGFR antibodies to produce an immunoliposome formulation- Ab-XYZ-I-73LnP (where ‘Ab’ denotes antibody-conjugated and ‘LnP’ denotes liposomal nanoparticle). In vitro efficacy was assessed by measuring cell viability and apoptosis in MiaPaCa-2 and PANC-1 cells, while pharmacokinetics and antitumor efficacy were determined in a cell line-derived xenograft (CDX) mouse model.

Results

Ab-XYZ-I-73LnP exhibited a mean particle size of 143nm ± 2.3, PDI (0.37), and zeta potential -46.2 ± 1.3mV. In MiaPaCa-2 cells, Ab-XYZ-I-73LnP showed remarkably higher cytotoxicity than 5-FU in both 2D (IC 50 = 2.5 ± 0.9μM vs 13.2 ± 1.1μM) and 3D cultures (IC 50 = 8.1 ± 1.1μM vs 26.7 ± 1.1 μM). Similarly, in PANC-1 cells, Ab-XYZ-I-73LnP showed lower IC 50 values compared to 5-FU;2D (IC 50 = 2.9 ±1.1 μM vs 20.4±1.2 μM), 3D (IC 50 = 12.9 ± 0.6μΜ vs 37.1±0.9 μM). Pharmacokinetic analysis revealed a prolonged half-life for Ab-XYZ-I-73LnP compared with free 5-FU (t1/2 = 1.62 ± 0.03 h vs 0.49 ± 0.01 h, p < 0.001). There was about a 2-fold increase in the area under the curve (AUC) for Ab-XYZ-I-73LnP compared to 5-FU (AUC= 0.32 ± 0.04µg/(L*hr) vs 0.15 ± 0.02µg/(L*hr), p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorouracilPancreatic NeoplasmsLiposomesDrug CarriersErbB ReceptorsAnimalsMiceXenograft Model Antitumor AssaysCell Line, TumorCell SurvivalApoptosisMolecular StructureNanoparticlesFemaleMice, Inbred NODMice, SCID

Stichwörter der Autor:innen

5-FUEGFRimmunoliposomespancreatic cancertargeted delivery

Substanzen

FluorouracilLiposomesDrug CarriersErbB ReceptorsLipid Nanoparticles

Autor:innen und Institutionen

  • College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA.
  • Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Department of Biobehavioral Nursing Science, College of Nursing, University of Florida, Gainesville, FL, USA.

ORCID-Profile: Esther Frimpong, Edward Agyare

Förderung

  • NCI NIH HHS
  • NIMHD NIH HHS
  • National Institute of Health (NIH) National Institute on Minority Health and Health Disparities
  • National Cancer Institute (NCI) of the National Institutes of Health

Zitieren

APA

Frimpong, E., Bulusu, R., Okoro, J., Zhu, X., Ablordeppey, J., Han, B., Yoon, S., & Agyare, E. (2026). Targeted Immunoliposomal Delivery of a 5-Fluorouracil Analog in EGFR-Expressing Pancreatic Cancer Models. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261468414

Vancouver

Frimpong E, Bulusu R, Okoro J, Zhu X, Ablordeppey J, Han B, et al. Targeted Immunoliposomal Delivery of a 5-Fluorouracil Analog in EGFR-Expressing Pancreatic Cancer Models. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261468414

BibTeX
@article{Frimpong2026,
  author = {Frimpong, Esther and Bulusu, Raviteja and Okoro, Joy and Zhu, Xue and Ablordeppey, Joshua and Han, Bo and Yoon, Saunjoo and Agyare, Edward},
  title = {Targeted Immunoliposomal Delivery of a 5-Fluorouracil Analog in EGFR-Expressing Pancreatic Cancer Models},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  volume = {25},
  doi = {10.1177/15330338261468414}
}
Kostenlos starten →